EGFR and non-small cell lung carcinoma: Transactivation of EGFR has been described for the proinflammatory cytokine interleukin (IL)-1β in different cells [21,22,23,24,25,26,27], including an NSCLC cell line [23], which raises the question of the possible involvement of EGFR even in IL-1β-induced TF expression.